Publications

726P Circulating cell-free DNA-based biomarkers as a new tool for prognosis and surveillance of adrenocortical carcinoma | Ronchi CL, et al. | Annals of Oncology | Oct. 2023

Improving hereditary hemorrhagic telangiectasia molecular diagnosis: A referral center experience | Aguilera C, et al | Genes | Mar. 2023

OR04-5 Circulating cell-free DNA-based biomarkers For prognostication and disease surveillance in adrenocortical carcinoma | Altieri B, et al | Journal of the Endocrine Society | Nov. 2022

Mutation detection in saliva from oral cancer patients | Ahmed AA, et al | Oral Oncology | Apr. 2024

Circulating tumour DNA detection by the urine-informed analysis of archival serum samples from muscle-invasive bladder cancer patients | BinHumaid FS, et al | European Urology | Jan. 2024

Custom panel implementation in patients with non-syndromic autism spectrum disorders in the clinical routine of a tertiary hospital | Sandoval-Talamantes AK, et al | Genes | Nov. 2023

Analysis of genetic variability in Turner syndrome linked to long-term clinical features | Suntharalingham JP, et al | Frontiers in Endocrinology | Sep. 2023

Minimal residual disease monitoring in radically treated non-small cell lung cancer: challenges and future directions | O’Sullivan HM, et al | OncoTargets and Therapy | Dec. 2023

Baseline mutations and ctDNA dynamics as prognostic and predictive factors in ER-positive/HER2-negative metastatic breast cancer patients | Pascual J, et al | Clinical Cancer Research | Oct. 2023

PB2000: A comprehensive NGS panel approach for clinical genomic analysis in haematological malignancy | Mason J, et al | HemaSphere | Aug. 2023